Posts by: Margarida Azevedo, MSc

Margarida Azevedo, MSc

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

August 9, 2016August 9, 2016

Wellness Advocate Starts Support Group for Chronic Pain, Other Invisible Illnesses in WA

News

Tracy Strand found herself out of luck when she tried to find a support group for people like her who deal with the everyday challenges of chronic pain, depression, anxiety and other ... Read more

August 8, 2016August 8, 2016

Fibromyalgia Patients Seen in Brain Scans to Have ‘Different Response’ to Hypnosis

News

Hypnotic suggestion — the act of offering an idea for action or for consideration of action— is an empirically validated form of pain control, although exactly how or why it helps to control pain remains unclear. Using brain scans in fibromyalgia patients under ... Read more

July 27, 2016July 27, 2016

2nd Phase 3 Study of Low-dose Oral Treatment for Fibromyalgia Gets Underway

News

Tonix Pharmaceuticals announced that the first patient has been dosed in RE-AFFIRM, the company’s second Phase 3 clinical trial evaluating its cyclobenzaprine HCl sublingual tablets, known as TNX-102 SL, as a low-dose nighttime treatment for fibromyalgia. TNX-102 SL ... Read more

July 25, 2016July 25, 2016

EULAR Favors Exercise as First Step in Managing Fibromyalgia

News

The European League Against Rheumatism (EULAR), in newly revised recommendations, highlights exercise as the strongest evidence-based therapy to manage fibromyalgia. These guidelines favor nonpharmacologic approaches as an initial treatment, with more personalized therapies in cases ... Read more

July 20, 2016July 20, 2016

Study Shows Fibromyalgia Patients Find Combination Therapy a More Effective Pain Treatment

News

Canada’s Queen’s University scientist Ian Gilron has found a more effective way to treat fibromyalgia by combining Lyrica (pregabalin), an anticonvulsant drug, with Cymbalta (duloxetine), an antidepressant. The study, “Combination of pregabalin with ... Read more

July 15, 2016July 15, 2016

Avacen Medical, Aiming for Global Growth, Chosen for Select Business Program and Awarded Grant

News

San Diego Mayor Kevin Faulconer and World Trade Center San Diego have jointly announced that Avacen Medical has been selected for the MetroConnect Program, a flagship initiative seeking to help local ... Read more

June 8, 2016June 8, 2016

2016 BIO International: Tonix Updates on Fibromyalgia, PTSD Medicine

News

Tonix Pharmaceuticals Holding Corp, focused on developing next-generation medicines for central nervous system disorders that include fibromyalgia and post-traumatic stress disorder (PTSD), presented reports at the recent 2016 BIO International Convention in San Francisco, ... Read more

June 6, 2016June 6, 2016

Balneotherapy, Patient Education Lead to Improvements in Fibromyalgia Patients, According to Study

News

Researchers at the Gaziantep University Faculty of Medicine in Turkey investigated the effects of balneotherapy on treatment of fibromyalgia compared to education alone and found that adding this therapy to ... Read more

May 27, 2016May 27, 2016

Fibromyalgia Treatment Often Depends on Physician’s Specialty

News

Despite published guidelines, fibromyalgia (FM) treatment still varies depending on physicians’ specialties, according to the findings of a study recently published Pragmatic and Observational Research. FM is a chronic pain condition, characterized by ... Read more

May 23, 2016May 23, 2016

Drug Used to Treat Fibromyalgia, Pregabalin, May Be Linked to Birth Defects

News

A drug used to treat fibromyalgia, epilepsy and other neuropathic conditions — pregabalin (marketed as Lyrica) — may be associated with an increased risk of major birth defects, including central nervous system and heart ... Read more